Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2017-12-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
2017年公开发行可转换公司债券信用评级报告
Regulatory Filings
2017-12-03 Chinese
国信证券股份有限公司关于公司公开发行可转换公司债券的发行保荐书
Capital/Financing Update Classification · 100% confidence The document is a detailed issuance sponsorship letter (保荐书) from Guosen Securities Co., Ltd. regarding the public issuance of convertible corporate bonds by Te Yi Pharmaceutical Group Co., Ltd. It includes extensive information about the issuer, the underwriting institution, legal compliance, financial conditions, risk factors, and regulatory adherence. The document references the China Securities Regulatory Commission and discusses the issuance of convertible bonds, including financial data, risk disclosures, and compliance with relevant laws and regulations. This type of document is a formal underwriting and sponsorship report related to a capital market transaction, specifically a convertible bond issuance. It is not a general annual or quarterly report, nor an earnings release or management discussion. It is not a simple announcement or a proxy statement. The content fits the category of Capital/Financing Update (CAP), as it provides comprehensive details on the financing activity of issuing convertible bonds, including underwriting and regulatory compliance information.
2017-12-03 Chinese
2017年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality of procedures and results of a specific shareholders' meeting (the 2017 second extraordinary general meeting) of a company. It details the convening, attendance, voting procedures, and results of the meeting, and concludes on the legality and validity of the meeting and its resolutions. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a shareholders' meeting. This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance document and does not fit other categories like AGM Information or Declaration of Voting Results, which would be more about the meeting materials or vote results announcements themselves rather than a legal opinion on the meeting's legality.
2017-11-29 Chinese
2017年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2017 second extraordinary general meeting of shareholders of 特一药业集团股份有限公司. It details the meeting date, voting methods, attendance, proposals voted on, voting results, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or detailed report content; rather, it is an official disclosure of voting results and meeting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is short (2377 characters), and it is not a report publication announcement or a full report. Therefore, the correct classification is DVA with high confidence.
2017-11-29 Chinese
关于控股股东股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the pledgee, the pledge period, and the impact on control and financial status. There is no financial report, earnings data, or management discussion. It is a regulatory disclosure about a significant shareholder's share pledge, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on share pledge details, not a full report or announcement of a report publication.
2017-11-28 Chinese
关于控股股东解除股票质押及部分股票再质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the release and re-pledging of shares by a controlling shareholder. It details the number of shares released from pledge and newly pledged shares, including dates and percentages. There is no financial statement, earnings data, or management discussion. The content focuses on share pledging activities by a major shareholder, which is related to capital structure but specifically about share pledging transactions. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is short (1416 characters) and is not merely an announcement of a report but a substantive update on share pledging. Therefore, the classification is CAP with high confidence.
2017-11-23 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.